Mads Krogsgaard Thomsen, CEO of Novo Nordisk Foundation, discusses European competitiveness.
President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland ...
El sector de renovables es el primero que muestra un impacto negativo por medidas de Trump, tras la orden de congelar nuevos ...
(Reuters) - European shares were subdued on Tuesday, as rising financials and healthcare shares countered broader losses ...
By Nikhil Sharma and Pranav Kashyap (Reuters) -European shares rose on Tuesday, buoyed by gains in the healthcare and luxury ...
La farmacéutica, con una capitalización de 380.000 millones, vende buena parte de sus fármacos en Estados Unidos ...
Eli Lilly (LLY 1.45%) began a roll in late 2020 that lasted almost four years. During that time, it became the world's ...
The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...
European shares held steady with slight gains in financials and healthcare despite global uncertainties over U.S. President Donald Trump's proposed tariffs. The market's cautious optimism was ...
Animal Político on MSN9d
Trump no propuso que el medicamento Ozempic se incluya en los programas sociales de MéxicoLa propuesta de la cobertura de Ozempic fue hecha por el gobierno del presidente Joe Biden para aplicarse en Estados Unidos y ...
For Novo Nordisk, a company still rooted in principles ... This is particularly the case in developing nations, from Mexico to the Gulf States, China and India, where healthcare systems are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback